Search
for

    Sort by

    Research 421–450 of 1000+

    1. First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study BMC Cancer · 2005 · 22 citations
    2. The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis Clinical breast cancer · 2019 · 18 citations
    3. Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link? PubMed · 2010 · 12 citations
    4. Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer Journal of Clinical Oncology · 2022 · 9 citations
    5. Postmillennial breast cancer photo-narratives: Technologized terrain Social Semiotics · 2012 · 9 citations
    6. Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries Cancer Medicine · 2017 · 8 citations
    7. Finasteride Use and Risk of Male Breast Cancer: A Case–Control Study Using Individual-Level Registry Data from Denmark, Finland, and Sweden Cancer Epidemiology, Biomarkers & Prevention · 2019 · 7 citations
    8. Hair safe study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy - A prospective interventional study The Breast · 2022 · 6 citations
    9. 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis International Braz J Urol · 2018 · 4 citations
    10. Quality of Life of Patients with Metastatic Breast Cancer Treated with Epirubicin and Docetaxel International Journal of Clinical Medicine · 2011 · 4 citations
    11. Anxiety, depression and quality of life in breast cancer patients undergoing chemotherapy in a tertiary care centre- a cross-sectional study Kerala Journal of Psychiatry · 2021 · 3 citations
    12. Advanced Breast Cancer in Young Women Journal of the National Cancer Institute · 2013 · 3 citations
    13. Alopecia Neoplastica: A Manifestation of Metastatic Breast Cancer Skin Health and Disease · 2023 · 2 citations
    14. Localised breast cancers may have systemic influences on skin and hair Journal of Clinical Pathology · 2006 · 2 citations
    15. Impact of CDK4/6 inhibitors on health-related quality of life outcomes in patients with metastatic breast cancer: A systematic review and meta-analysis Journal of Managed Care & Specialty Pharmacy · 2025 · 1 citations
    16. Male breast cancer after finasteride therapy for benign prostate hyperplasia Urological Science · 2013 · 1 citations
    17. Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq” Journal of cancer research updates · 2026
    18. FEMALE BREAST CANCER PROTECTION USING PHYTOESTROGEN LIGNANS FROM FLAXSEED International Journal of Pharmacology · 2026
    19. Symptom Clusters in Brazilian Women With Stage I and Stage III Nonmetastatic Breast Cancer: A Cross‐Sectional Study The Breast Journal · 2026
    20. Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion npj Breast Cancer · 2025
    21. Clinical and genetic predictors of persistent chemotherapy-induced alopecia despite scalp cooling in breast cancer npj Breast Cancer · 2025
    22. Safety and patient-reported outcomes in patients with hormone receptor-positive, HER2-negative advanced breast cancer treated with CDK4/6 inhibitors in China: A cross-sectional study. Journal of Clinical Oncology · 2024
    23. Ductal breast cancer in a male patient International Journal of Dermatology · 2010
    24. The Breast Cancer Wars: Fear, Hope and the Pursuit of a Cure in Twentieth Century America Journal of the Royal Society of Medicine · 2003
    25. Immunohistochemical demonstration of breast‐derived and/or carcinoma‐associated glycoproteins in normal skin appendages and their tumors Journal of Cutaneous Pathology · 1992 · 71 citations
    26. Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents Annals of Oncology · 2005 · 67 citations
    27. Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling International Journal of Oncology · 2014 · 53 citations
    28. Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review Pharmacological Reviews · 2022 · 49 citations
    29. Endocrine correlates of male breast cancer risk: a case-control study in Athens, Greece British Journal of Cancer · 2000 · 30 citations
    30. Activation of AR Sensitizes Breast Carcinomas to NVP-BEZ235's Therapeutic Effect Mediated by PTEN and KLLN Upregulation Molecular cancer therapeutics · 2013 · 23 citations